Bionano Genomics, Inc. (BNGO) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Bionano Genomics, Inc. (BNGO) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $13.4M, listed on NASDAQ, employing roughly 96 people, carrying a beta of 1.62 to the broader market. Bionano Genomics, Inc. Led by Albert A. Luderer, public since 2018-08-21.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for BNGO as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →